Name: Cadrenal Therapeutics, Inc. (CVKD) Balance Sheet
Creator: FinSpry

Cadrenal Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Cadrenal Therapeutics, Inc. (CVKD) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Current Assets
Cash and Cash Equivalents	10.02	8.40	0.03
Cash & Short-Term Investments	10.02	8.40	0.03
Accounts Receivable	0.04	0.04	0.00
Inventory	0.00	0.00	0.00
Other Current Assets	0.06	0.22	0.02
Total Current Assets	10.11	8.49	0.73
Non-Current Assets
Property, Plant & Equipment (Net)	0.01	0.02	0.04
Other Non-Current Assets	0.00	0.00	0.01
Total Non-Current Assets	0.01	0.03	0.05
Total Assets	10.12	8.52	0.78
Current Liabilities
Accounts Payable	1.50	0.17	0.40
Short-Term Debt	0.00	0.00	0.04
Accrued Liabilities	0.21	0.04	0.86
Other Current Liabilities	1.18	0.60	0.00
Total Current Liabilities	2.68	0.83	1.33
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.55
Other Non-Current Liabilities	0.00	0.00	4.42
Total Non-Current Liabilities	0.00	0.00	4.99
Total Liabilities	2.68	0.83	6.33
Stockholders' Equity
Common Stock	0.00	0.00	0.01
Retained Earnings	-25.72	-15.07	-6.71
Additional Paid-in Capital	33.16	22.76	1.15
Shares Outstanding	1.78	0.87	0.78
Total Stockholders' Equity	7.44	7.69	-5.55
Total Liabilities & Equity	10.12	8.52	0.78